Anxiety, Depression, and Post-traumatic Stress Disorder Symptoms in Patients Treated With Immunosuppressive Drugs During the COVID-19 Pandemic

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Ehsani Maryam; Seyedfatemi Naeimeh; Haghani Shima; Abbasi Amirhojjat

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iran Journal of Nursing Year:2023 | Volume:36 | Issue:144 Page(s): 424-437

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Anxiety, Depression, and Post-traumatic Stress Disorder Symptoms in Patients Treated With Immunosuppressive Drugs During the COVID-19 Pandemic

Author(s)

Ehsani Maryam | Seyedfatemi Naeimeh | Haghani Shima | Abbasi Amirhojjat | Issue Writer Certificate

Keywords

AnxietyQ4

DepressionQ4

Post-traumatic stress disorderQ4

Immunosuppressive drugsQ4

COVID-19Q4

Abstract

Background & Aims Despite the significant impact of Immunosuppressive drugs on controlling and treating certain diseases, their continued use can predispose patients to infectious diseases such as COVID-19, leading to Anxiety, Depression, and Post-traumatic stress disorder (PTSD) symptoms. This study aims to determine the levels of Anxiety, Depression, and PTSD symptoms in patients treated with immunosuppressive drug during the COVID-19 pandemic. Materials & Methods This descriptive cross-sectional study was conducted on 330 individuals treated with immunosuppressive drug such as those with autoimmune diseases, cancer, and transplant recipients in Firoozgar and Rasoul-e-Akram hospitals in Tehran, Iran, from July to December 2022. They were selected using a continuous sampling method. The instruments were a demographic/disease-related questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Impact of Event Scale-Revised (IES-R). Data analysis was done in SPSS software, version 16 using descriptive (frequency, percentage, mean, standard deviation) and inferential (Independent t-test, analysis of variance, and Pearson’s correlation test) statistics. Results In this study, the mean age of participants was 51. 35±12. 95 years, and 148 (44. 8%) were female. The majority of the patients had normal levels of Anxiety and Depression (91. 2% and 92. 1%, respectively). The mean total IES-R score was 27. 71 out of 88. The Anxiety and Depression scores did not have a significant relationship with any demographic, disease-related, and COVID-related characteristics of the study participants, but a significant correlation between income level and total score of IES-R was observed (P=0. 043). Conclusion The individuals receiving Immunosuppressive drugs in this study, despite being susceptible to COVID-19, had normal levels of Anxiety and Depression and obtained lower than average score in the IES-R. This finding can reduce the concerns about the mental health of these patients. Further studies using other questionnaires or a qualitative study on the expriences of these patients during the COVID-19 pandemic are recommended.

Cites

No record.

References